Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 8

1.

Autoantibody Development under Treatment with Immune-Checkpoint Inhibitors.

de Moel EC, Rozeman EA, Kapiteijn EH, Verdegaal EME, Grummels A, Bakker JA, Huizinga TWJ, Haanen JB, Toes REM, van der Woude D.

Cancer Immunol Res. 2019 Jan;7(1):6-11. doi: 10.1158/2326-6066.CIR-18-0245. Epub 2018 Nov 13.

PMID:
30425107
2.

CD20 deficiency in humans results in impaired T cell-independent antibody responses.

Kuijpers TW, Bende RJ, Baars PA, Grummels A, Derks IA, Dolman KM, Beaumont T, Tedder TF, van Noesel CJ, Eldering E, van Lier RA.

J Clin Invest. 2010 Jan;120(1):214-22. doi: 10.1172/JCI40231. Epub 2009 Dec 21.

3.

Chronic lymphocytic leukemia cells display p53-dependent drug-induced Puma upregulation.

Mackus WJ, Kater AP, Grummels A, Evers LM, Hooijbrink B, Kramer MH, Castro JE, Kipps TJ, van Lier RA, van Oers MH, Eldering E.

Leukemia. 2005 Mar;19(3):427-34.

PMID:
15674362
4.

Expression profiling via novel multiplex assay allows rapid assessment of gene regulation in defined signalling pathways.

Eldering E, Spek CA, Aberson HL, Grummels A, Derks IA, de Vos AF, McElgunn CJ, Schouten JP.

Nucleic Acids Res. 2003 Dec 1;31(23):e153.

5.

Expansion of CMV-specific CD8+CD45RA+CD27- T cells in B-cell chronic lymphocytic leukemia.

Mackus WJ, Frakking FN, Grummels A, Gamadia LE, De Bree GJ, Hamann D, Van Lier RA, Van Oers MH.

Blood. 2003 Aug 1;102(3):1057-63. Epub 2003 Apr 10.

6.

In vitro differentiation characteristics of human skin fibroblasts: correlations with radiotherapy-induced breast fibrosis in patients.

Russell NS, Lara PC, Grummels A, Hart AA, Coco-Martin JM, Bartelink H, Begg AC.

Int J Radiat Biol. 2000 Feb;76(2):231-40.

PMID:
10716644
7.

Low predictive value of intrinsic fibroblast radiosensitivity for fibrosis development following radiotherapy for breast cancer.

Russell NS, Grummels A, Hart AA, Smolders IJ, Borger J, Bartelink H, Begg AC.

Int J Radiat Biol. 1998 Jun;73(6):661-70.

PMID:
9690684
8.

Chemical characterization and comparative cellular effects of meta-iodobenzyl guanidine and benzyl guanidine.

Van den Berg JD, Smets LA, Rutgers M, Grummels A, Fokkens R, Jonkergouw P, van Rooij H.

Cancer Chemother Pharmacol. 1997;40(2):131-7.

PMID:
9182834

Supplemental Content

Loading ...
Support Center